India, April 27 -- image credit- freepik

Metropolis Healthcare has announced the launch of an advanced blood-based test designed to support earlier detection and more informed clinical decisions in Alzheimer's disease.

Alzheimer's disease (AD) is defined by its unique neuropathologic findings; hence diagnosis is based on clinical context, neuroimaging findings, and presence of accurate biomarkers in the intended population by which AD staging is done. Alzheimer's disease remains significantly underdiagnosed in its early stages, particularly among individuals over the age of 50, where cognitive decline is often overlooked or misattributed. 

Metropolis' newly introduced blood-based test enables minimally invasive screening through a...